DUTCHIE CELEBRATES HISTORIC CANNABIS RECLASSIFICATION FROM SCHEDULE I TO SCHEDULE III
The reclassification removes the 280E tax penalty, potentially benefiting 425,000 U.S. cannabis workers and enabling FDA and DEA regulation under a pharmaceutical framework.
- Yesterday, HYTN Innovations Inc. acknowledged the U.S. administration issued an executive order to start Schedule III reclassification, and CEO Elliot McKerr said the company welcomes the development.
- A Schedule III designation would align cannabis with acetaminophen with codeine and testosterone, reflecting accepted medical use while maintaining regulation by the U.S. Food and Drug Administration and Drug Enforcement Administration.
- HYTN Innovations Inc. says it maintains a GMP platform, holds a Health Canada Drug Establishment Licence, a Certificate of GMP Conformity for the U.S., and exports to the United Kingdom, Germany, and Australia.
- Ending the 280E tax penalty would empower 425,000 people working in the U.S. cannabis industry and enable broader support from U.S. financial and banking institutions, Dutchie said.
- HYTN says its GMP capabilities position it to assess opportunities, but it warned the executive order may be delayed or limit operations in U.S. markets under the federal regulatory process.
40 Articles
40 Articles
DUTCHIE CELEBRATES HISTORIC CANNABIS RECLASSIFICATION FROM SCHEDULE I TO SCHEDULE III
BOSTON, Dec. 18, 2025 /PRNewswire/ -- Dutchie, a leading cannabis technology software platform powering over 6,5000 cannabis businesses throughout the U.S. and Canada, commends today's historic executive order expediting the reclassification of cannabis from a Schedule I controlled substance to…
The Chinese producers in the United States are approaching a major change in how they are treated by the U.S. tax system. The Drug Control Administration (DEA) announced that it is starting the process of reclassifying marijuana from Schedule I in Schedule III, which could radically transform the financial situation of the industry. This movement comes [...]
Coverage Details
Bias Distribution
- 54% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




















